Ara
Toplam kayıt 6, listelenen: 1-6
Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
(Elsevier Ireland Ltd., 2016)
Objective: The aim of the present study was to investigate the relationship between glomerular filtration rate (GFR) and acute post-scaffold recoil (PSR) in patients undergoing bioresorbable scaffold (BVS) implantation. ...
Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: A single-centre experience
(Taylor and Francis, 2017)
Objective In modern cardiology practice, implantation of cardiac electronic devices in patients taking anticoagulant or antiplatelet therapy is a common clinical scenario. Bleeding complications are of particular concern ...
Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds
(Wiley, 2017)
Objectives: We aimed to evaluate the peri-procedural success of DESolve bio-resorbable scaffolds (BRSs) and analyzed real-life data about major cardiac events during 1-year follow-up. Background: There is little information ...
The relationship between the S-wave in lead 1 and recurrence of RVOT PVC ablation
(Churchill Livingstone Inc Medical Publishers, 2018)
Background: Radiofrequency catheter ablation (CA) is a common non-pharmacological treatment option for ventricular premature contractions (PVCs) originating from right ventricular outflow tract (RVOT). In this study, we ...
A novel predictor of radial spasm: Arterial stiffness
(Lippincott Williams & Wilkins, 2018)
ObjectiveIn this study, we aimed to assess the relationship between radial artery spasm (RAS) and arterial stiffness (AS) measured by the oscillometric method.Materials and methodsA total of 123 consecutive patients scheduled ...
Long-term outcomes of patients presenting with acute coronary syndrome and implanted with bioresorbable scaffold
(Yuzuncu Yıl University Faculty of Medicine, 2022)
A bioresorbable scaffold (BRS) has been used in the latest stages of stent technology and is a less-known material than drug-eluting stents (DES). In this study, we aimed to evaluate the long-term clinical outcomes of BRS ...